pubrio
Alto Neuroscience logo

Alto Neuroscience

Public
altoneuroscience.com
生物技术81 employeesFounded 2019🇺🇸 美国

Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.

成立年份
2019
员工人数
81
行业
生物技术
公司类型
Public Company
股票
nasdaq: ANRO
总部
🇺🇸Mountain View, California (+1)
专长
制药行业生物技术医疗保健

扩张情报

全新 · 仅在 Pubrio

我们正在追踪 Alto Neuroscience 的市场扩张

全球扩张

实时
阶段
探索中投入中进入中运营中
了解一下

关于 Alto Neuroscience 的常见问题

关于 Alto Neuroscience 的业务、市场和增长信号的快速解答。

Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。